insights_auto
Hvorfor har BVNRY gått opp? 2,26%?
GÃ¥ mer i dybdenchevron_right
BVNRY:OTCMKTS
Bavarian Nordic
11,08Â USD
arrow_upward
+2,26%(+0,24) 1Â D
5. okt., 16:00:00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for BVNRY …
Ã…pne
11,02Â USD
Høy
11,08Â USD
Lav
11,02Â USD
Markedsverdi
2,64Â mrd.
Snittvolum
3,97k
Volum
1,24k
P/E-forhold
11,85
52 u høy
13,00Â USD
52Â u lav
8,67Â USD
EPS
0,94Â USD
Beta
1,45
Utestående aksjer
237,82Â mill.
Antall ansatte
2k
Ã…pne
11,02Â USD
Høy
11,08Â USD
Lav
11,02Â USD
Markedsverdi
2,64Â mrd.
Snittvolum
3,97k
Volum
1,24k
P/E-forhold
11,85
52 u høy
13,00Â USD
52Â u lav
8,67Â USD
EPS
0,94Â USD
Beta
1,45
Utestående aksjer
237,82Â mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
GlobeNewswire
·
for 23 timer siden
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Om Bavarian Nordic
Administrerende direktørPaul Chaplin
Ansatte1,91k
Grunnlagt1. juli 1992
Hovedkontor-
Sektor-
Nettstedbavarian-nordic.com